To maintain a leadership position in aesthetic treatments, core specialists must identify and embrace the game-changing innovations of the future, says an expert. To that end, he recommends participating in drug and device development and clinical trials.
There is evidence of how light or laser therapy may stimulate hair growth, according to an expert who spoke at a dermatology symposium about the facts and myths of laser and light therapy.
Regardless of the specialty, one commonality that has resulted from the multitudinous technologic advances and the improved quality and quantity of life is that they have all come at a significant cost.
Photodynamic therapy applied every other month shows promise as a chemopreventive regimen, while thermal PDT appears to offer better photosensitizer uptake and long-term results than standard PDT, experts say.
For years, cosmetic chemists have been looking for the mechanism whereby the skin remains naturally moisturized, and it has recently been identified.
The “Chaos & Clues” decision algorithm allows physicians to decide for or against biopsy at the speed of a normal examination, without making complex calculations, one of its developers says.
As researchers learn more about the pathogenesis of rosacea, they can better understand the benefits of certain medications and find opportunities for new therapies.
In treating nonmelanoma skin cancers, an expert says, superficial radiation therapy appears poised for a resurgence due to factors including its safety, efficacy and cost-effectiveness.
Oral terbinafine has been the gold standard for treatment of onychomycosis for more than 20 years, but development of new therapeutic options has been the focus of some significant research activity.
Dermatologists can expect to see highly effective systemic and oral therapeutic options for psoriasis and psoriatic arthritis added to their toolbox.
Captive insurance companies can help physicians manage financial risks, reduce taxable income by hundreds of thousands of dollars per year, and build a side fund to help manage future changes.
The past few years have been an exciting time for those who treat psoriasis and for many patients with severe disease because of excellent new therapies for this often intractable problem. Norman Levine, M.D., talks with Alan Menter, M.D., Baylor University Medical Center, Dallas, about recent developments in the treatment of psoriasis.
Though a cure for melanoma remains elusive, continued research has borne several promising treatment approaches with more targeted drugs that can help lengthen melanoma patients' survival, buying them time until more effective treatments come to light.
Understanding key elements of the sales process is key to managing treatment plans and expectations for many aesthetic procedures.
From branding to business basics, the technology startup companies of Silicon Valley offer lessons for entrepreneurs including core aesthetic medicine specialists, an expert says.
Are you a dermatologist using social media to market your practice? Wondering which metrics you should be paying attention to? The answer is a lot easier than you think.
New research suggests botulinum toxin type A has anti-depressive qualities along with its well-known cosmetic effects.
New York dermatologist Mark Lebwohl, M.D., was named president-elect of the American Academy of Dermatology at the academy’s 72nd annual meeting recently.
The Senate passed another one-year fix to the sustainable growth rate (SGR) formula, to the dismay of the American Academy of Dermatology Association and numerous other physician advocate groups.
Scars happen. Doing a routine skin biopsy, performing a surgical facial rejuvenation treatment or Mohs surgery - dermatologists and cosmetic surgeons cause scars. But they can also treat them.
On the final day of the 72nd Annual Meeting of the American Academy of Dermatology, clinicians shared clinical pearls regarding psoriasis comorbidities, isotretinoin dosing for acne and how to treat patients with body dysmorphic disorder.
In the battle against melanoma, a new test has shown that it can identify primary cutaneous melanomas that are likely to metastasize in patients who had negative sentinel lymph node biopsies (SLNB). Data were presented at the 72nd Annual Meeting of the American Academy of Dermatology.
There is a misconception that people with skin of color are not at risk of skin cancer, and dermatologists are responsible for better educating themselves and their patients about this danger, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
In discussing tropical skin ailments that can affect children, Scott A. Norton, M.D., presented cases at the 72nd Annual Meeting of the American Academy of Dermatology using a “Jeopardy” format that required students in the audience to frame their diagnoses as questions based on the symptoms outlined.
A new study strongly links pulmonary complications to survival rates among scleroderma patients.
The Food and Drug Administration has approved an oral medication, Otezla (apremilast, Celgene) for the treatment of adult patients with active psoriatic arthritis.
Smart fractional technology represents an exciting development for medical treatments with fractional lasers, says an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Active chemicals found in the neem tree (Azadirachta indica) have important benefits for a variety of skin disorders, according to one expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
When patients present with hair loss, dermatologists should focus most heavily on patient histories, according to an expert who spoke at the 72nd Annual Meeting of the American Academy of Dermatology.
Selecting the appropriate drug category is important to effectively manage itch, Sarina Elmariah, M.D., Ph.D., told attendees at the 72nd Annual Meeting of the American Academy of Dermatology.
